North Carolina center for improving blood-based cancer screening
Cancer Screening Research Network - North Carolina Hub (CSRN-NC HUB)
Researchers will test new blood tests that can look for many cancers at once with adults across North Carolina to learn their benefits and risks.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11252868 on NIH RePORTER |
What this research studies
If you join, you may be asked to give a blood sample so researchers can look for signs of multiple cancers using cell-free DNA. The UNC Lineberger hub will work with UNC Health and community clinics statewide to include people from different backgrounds and areas. The project will compare how these multi-cancer detection tests perform, track any follow-up testing and outcomes, and study the best ways to offer the tests in real-world care. The goal is to speed up research while making sure benefits and harms are understood for patients like you.
Who could benefit from this research
Good fit: Adults living in North Carolina who are willing to provide a blood sample and participate through UNC Health or partner community clinics are the ideal candidates.
Not a fit: People whose cancers are already diagnosed or who are only eligible for guideline-based single-cancer screening may not see direct benefit from these multi-cancer screening tests.
Why it matters
Potential benefit: If successful, this work could lead to a single blood test that finds many cancers earlier, potentially catching cancers sooner and lowering deaths.
How similar studies have performed: Early research on multi-cancer blood tests has shown promising detection in some studies, but wider real-world benefit and best-use practices are still being worked out.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Reuland, Daniel S. — Univ of North Carolina Chapel Hill
- Study coordinator: Reuland, Daniel S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.